Biosensors & POCT– category –
-
FDA Reclassifies SARS-CoV-2 POCT Devices to Class II, Easing Regulatory Burden for Rapid Diagnostics
GovInfo (Federal Register) USA Overview The U.S. FDA has issued a final rule, effective June 11, 2026, reclassifying simple point-of-care (POCT) devices for direct detection of SARS-CoV-2 viral targets to Class II (special controls). Thi... -
Continuous Glucose Monitoring (CGM) Study Reveals Correlation Between Glycemic Variability and Headache Intensity in Chronic Migraine Patients
Ethnobotany Research and Applications Unknown Overview A continuous glucose monitoring (CGM) study on chronic migraine patients revealed that participants experienced significant postprandial glycemic variability during waking hours, and... -
Wearable Device ‘Disappearing Act’ Accelerates as Dexcom’s Latest CGM Shrinks by 50%
ZDNET USA Overview Wearable devices are evolving towards 'invisible' designs to integrate more naturally into users' lifestyles, aiming to minimize their presence and enable more consistent wear, thereby enhancing user experience. Dexcom... -
Tufts University Pioneers New Applications for Bioengineered Bacterial Spores as Biosensors and Catalysts
Tufts Now USA Overview Researchers at Tufts University have discovered novel methods to utilize bioengineered bacterial spores for a broad range of applications, including catalysis of chemical reactions, biofuel production, pollutant de... -
Precision and Provenance: Why Regulatory Approval and MARD Transparency Define the Future of Glucose Monitoring
Mattioli 1885 イタリア Overview A recent report on the 2026 glucose monitoring market highlights the transformative role of Continuous Glucose Monitoring (CGM) in diabetes management. It underscores that robust quality indicators—specifi... -
2026 Digital Blood Sugar Meters: CGM Revolutionizes Metabolic Awareness with Real-Time Trends and Historical Data
[Unnamed Health Publication] Unknown Overview An analysis of digital blood sugar meters in 2026 highlights the distinction between traditional meters, which provide single readings, and Continuous Glucose Monitoring (CGM) devices that of... -
Abbott’s FreeStyle Libre Offers 10-Day Real-Time Glucose Monitoring for Diabetes Patients Aged 4 and Up
Health Insider Canada Overview Abbott Laboratories' FreeStyle Libre system provides continuous glucose monitoring for diabetes patients aged four and older, utilizing a small wearable sensor and a smartphone app. This system delivers rea... -
Umeå University Breakthrough: ‘Plastic Antibodies’ Advance Detection of Challenging Hydrophilic Analytes
Umeå University スウェーデン Overview Chau Minh Huynh at Umeå University has developed pioneering molecularly imprinted monoliths (MIPs), often termed 'plastic antibodies,' specifically engineered to target challenging hydrophilic analyt... -
FDA Warns: Smartwatches Lack Medical-Grade Accuracy for Non-Invasive Blood Glucose Monitoring in 2026
[Unnamed Health Publication] USA Overview As of 2026, peer-reviewed research on non-invasive blood glucose monitoring via consumer wearables remains limited. The FDA and Johns Hopkins University explicitly state no wrist-worn device exis... -
Smart Sensor Technology Advances Across Healthcare, Environmental, Manufacturing, and Agricultural Sectors, Driving Diagnostics and Flexible Devices
Knowledge Unknown Overview The evolution of smart sensor technology is dramatically advancing diverse application areas, including healthcare, environmental monitoring, smart manufacturing, and precision agriculture. In healthcare, flexi...
